Monoclonal antibodies for inducing tolerance
CA 2055615 C · Owner: Cobbold, Stephen Paul · Inventors: Waldmann, Herman; Cobbold, Stephen Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of a non-depleting anti-CD4 monoclonal antibody for the manufacture of a medicament for the induction of a state of immunological tolerance to an antigen by a method which comprises administering said non-depleting anti-CD4 monoclonal antibody to a subject together with a non-depleting anti-CD8 monoclonal antibody to induce an immunological tolerance permissive environment within said subject by means of said antibodies in the presence of said antigen. Also, the invention relates to a pharmaceutical composition in unit dose form comprising from 1 to 400 mg per unit dose of a non-depleting anti-CD4 antibody or a non-depleting anti-CD8 antibody …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 31, 1990 and granted July 17, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 31, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 31, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.